Skip to Content
Merck

Your mRNA Therapeutics

Solutions at any scale, in-house or outsourced. With our industry-leading technologies, expertise, and services.

HomeIntegrated OfferingsmRNA Therapeutics

mRNA Therapeutics

mRNA technology and lipid nanoparticle (LNP) delivery systems have revolutionized vaccine development and other therapeutic applications. Whether you are in research, development, or manufacturing, our comprehensive portfolio of products, services, contract development and manufacturing capabilities, and expertise provides everything you need for mRNA synthesis, purification, and formulation. By partnering with us, you can expect direct and flexible interactions and technical support anywhere along your mRNA molecule’s journey.  

Our Products and Services Support the Following Areas

Research

Test
  • Antigen Discovery Products
  • mRNA Synthesis
  • LNP Selection and Formulation

    Development

    mRNA-development
    • Characterization and Method Development
    • Plasmid DNA Production and mRNA Synthesis & Purification
    • mRNA Contract Development and Manufacturing Services
    • Lipid Nanoparticle Formulation (LNP)
    • Preclinical Assessment
    • mRNA Development Services

      Manufacturing & Formulation

      mRNA-manufacturing-and-formulation
      • mRNA Synthesis and Purification Products
      • mRNA Contract Development and Manufacturing Services
      • Lipid Nanoparticle Formulation (LNP)
      • Cell Banking and Storage
      • Facility Engineering Services
      • mRNA Testing Services

        Analytical & Quality Control

        mRNA-analytics-and-quality-control
        • Analytical Quality Control
        • Microbial Quality Control

          mRNA technologies offer a simplified manufacturing process, which uses the same reaction materials and vessels for any target. This allows GMP facilities to switch to a new protein target within very short time periods and with minimal adaptation to process and formulation. In our technical article, "Manufacturing Strategies for mRNA Vaccines and Therapeutics" we discuss many of the considerations for the mRNA manufacturing process.

          Sign In To Continue

          To continue reading please sign in or create an account.

          Don't Have An Account?